Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2240 (LINC02240)

Target
LINC02240
Molecular classification
Other (long non-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 2240 (LINC02240) is a human lncRNA gene transcript with no protein-coding potential. Functionally, LINC02240 acts as a molecular sponge for miR-7-5p, which leads to upregulation of EGFR expression, thereby promoting cell invasion and migration in non-small cell lung cancer. Its expression profile and role in modulating miRNA networks indicate possible utility as a biomarker and a promising therapeutic target in oncology. However, its molecular characterization and therapeutic potential require further direct validation, as most evidence derives from studies of related lncRNAs and from gene expression analyses. LINC02240 is classified under long non-coding RNA genes and is not a protein-coding gene, nor does it fit into traditional families like receptors, enzymes, or ion channels. Most information is based on transcriptomic databases and cancer biology studies documenting the regulatory effects of similar lincRNAs. There is currently no known drug approved or in active clinical development that specifically targets LINC02240, though its modulation of cancer cell behavior suggests future potential in precision medicine approaches.

Other names
LINC02240long intergenic non-protein coding RNA 2240
02

Mechanism of action

miRNA sponge (regulates miR-7-5p; thus may indirectly alter EGFR signaling and gene expression, which impacts cell migration and invasion in cancer models)

03

Biological functions

miRNA sponge (competitive endogenous RNA)Regulation of gene expressionModulation of cell invasion and migrationInfluences cell proliferation and differentiation (inferred from lncRNA function, as direct evidence for LINC02240’s specific activities is not yet established but supported for similar lincRNAs)
04

Disease associations

Cancer (specifically implicated in non-small cell lung cancer, may also have potential roles in other malignancies as candidate based on similar lincRNA functions)
05

Safety considerations

No specific safety concerns for direct targeting therapeutics published to date; general challenges include delivery, potential off-target effects, and incomplete mechanistic understanding typical of lncRNA therapies
06

Biomarkers

Expression level of LINC02240 may serve as a biomarker in non-small cell lung cancer for diagnosis and prognosis

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2240 (LINC02240).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2240 (LINC02240).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call